Key facts
- Aipuqiang’s last known valuation is $135.2M (Jun 2023).
- It has raised $254.3M; the latest was Later Stage VC ($141.7M) in Dec 2025.
- Notable investors include New Alliance Capital, Xuhui Hi-Tech, Shanghai Alliance Investment, Shanghai Information Investment, Jiading Industry Development Group — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Aipuqiang
- ·The full record, as it builds
Funding rounds
No funding rounds for Aipuqiang are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aipuqiang
Manufacturer of proton therapy systems designed for hospitals, cancer treatment centers, and healthcare institutions. The company focuses on the research and development of proton therapy devices, thereby enabling clients to provide patients with state-of-the-art, non-invasive cancer therapy options that improve treatment outcomes.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2011
- Employees
- 68
- Website
- aptr.com.cn/
- Ownership
- Privately Held (backing)
Aipuqiang doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aipuqiang shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aipuqiang in its N-PORT filings yet. We sweep new filings monthly.